Metallothionein Lower Under-Expression in Benign Tumors than That in Malignant Tumors: Systematic Review Article and Meta-Analysis.

Metallothionein (MT) manifests varying expression levels in carcinomas, and they may be considered as valuable cell cancerization biomarkers for diagnosis of patients with cancers. A meta-analysis was conducted to evaluate comprehensively the MT expression difference in various benign tumors and mal...

Full description

Bibliographic Details
Main Authors: Jie Zhang, Ruijie Sun, Yue Liu, Guinian Wang, Qinglu Wang
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2014-06-01
Series:Iranian Journal of Public Health
Subjects:
Online Access:https://ijph.tums.ac.ir/index.php/ijph/article/view/4080